Sukhi Thethy
Comptroller/Controller/Auditor bei CHINOOK THERAPEUTICS, INC.
Profil
Sukhi Thethy is currently the Senior VP-Finance & Accounting at Chinook Therapeutics, Inc. Previously, Thethy worked as the Vice President & Controller at Aimmune Therapeutics, Inc. Thethy is a graduate of San Jose State University.
Aktive Positionen von Sukhi Thethy
| Unternehmen | Position | Beginn |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Ehemalige bekannte Positionen von Sukhi Thethy
| Unternehmen | Position | Ende |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Sukhi Thethy
| San Jose State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
